(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Remote Headphones: Upgrade Your Sound Insight - 2Manual for Financial plan Agreeable PC
- 3Flu season is ramping up, and some experts are "pretty worried"
- 4Kiev declares energy emergency after Russian attacks amid winter cold
- 5It's your last chance to subscribe to Paramount+ before they raise their prices: Here's how to lock in current pricing
- Public Parks in the USA
- Nurturing Hacks: Astuteness from Experienced Mothers and Fathers
- The Best Computer games for Multiplayer Fun
- The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
- Chicago reports first rabies-positive dog in 61 years. What we know.
- Which sandwich do you find totally delectable? !
- 6 Travel Services for Colorful Get-aways: Pick Your Fantasy Escape
- PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
